← Leaderboards
Alexander E. Perl
University Of Pennsylvania
$861,840
Attributed
$861,840
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $172.4K · FY2010–14$200K$150K$100K$50K$0
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$861,840 · 1
By mechanism
K23$861,840 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Vera P Krymskaya$16,207,847
- E. Jane Albert Hubbard$13,066,235
- Meenhard Herlyn$50,214,821
- Jay L. Hess$7,945,973
- Theresa M Busch$13,382,890
Others in their field
Top investigators on “Elements”
- Richard K. Wilson · Washington University$332,639,077
- Barton F Haynes · Duke University$292,876,624
- Eric S Lander · Whitehead Institute For Biomedical Res$232,780,693
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$186,492,164
- David W Simpson · University Of Southern California$143,628,960
Research focus
Elements1-Phosphatidylinositol 3-KinaseAmericanBiologyBlast CellAntineoplastic AgentsBaseCareerCellsCell SurvivalCessation Of LifeChemotherapyClinicClinical CareClinical TrialsConduct Clinical TrialsCytarabineCytotoxicCytotoxic ChemotherapyDiagnosisDoseDrug ExposureDrug KineticsEtoposide
Grant awards (5)
mTOR Inhibition as a Therapeutic Strategy for Acute Myeloid Leukemia$172,368
K23 · FY2014 · CA · contact PI
mTOR Inhibition as a Therapeutic Strategy for Acute Myeloid Leukemia$172,368
K23 · FY2013 · CA · contact PI
mTOR Inhibition as a Therapeutic Strategy for Acute Myeloid Leukemia$172,368
K23 · FY2012 · CA · contact PI
mTOR Inhibition as a Therapeutic Strategy for Acute Myeloid Leukemia$172,368
K23 · FY2011 · CA · contact PI
mTOR Inhibition as a Therapeutic Strategy for Acute Myeloid Leukemia$172,368
K23 · FY2010 · CA · contact PI